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Abstract
Background: The modulation of gap junctional communication between tumor cells and between tumor
and vascular endothelial cells during tumorigenesis and metastasis is complex. The notion of a role for loss
of gap junctional intercellular communication in tumorigenesis and metastasis has been controversial.
While some of the stages of tumorigenesis and metastasis, such as uncontrolled cell division and cellular
detachment, would necessitate the loss of intercellular junctions, other stages, such as intravasation,
endothelial attachment, and vascularization, likely require increased cell-cell contact. We hypothesized
that, in this multi-stage scheme, connexin-43 is centrally involved as a cell adhesion molecule mediating
metastatic tumor attachment to the pulmonary endothelium.
Methods: Tumor cell attachment to pulmonary vasculature, tumor growth, and connexin-43 expression
was studied in metastatic lung tumor sections obtained after tail-vein injection into nude mice of syngeneic
breast cancer cell lines, overexpressing wild type connexin-43 or dominant-negatively mutated connexin-
43 proteins. High-resolution immunofluorescence microscopy and Western blot analysis was performed
using a connexin-43 monoclonal antibody. Calcein Orange Red AM dye transfer by fluorescence imaging
was used to evaluate the gap junction function.
Results: Adhesion of breast cancer cells to the pulmonary endothelium increased with cancer cells
overexpressing connexin-43 and markedly decreased with cells expressing dominant-negative connexin-
43. Upregulation of connexin-43 was observed in tumor cell-endothelial cell contact areas in vitro and in
vivo, and in areas of intratumor blood vessels and in micrometastatic foci.
Conclusion: Connexin-43 facilitates metastatic 'homing' by increasing adhesion of cancer cells to the lung
endothelial cells. The marked upregulation of connexin-43 in tumor cell-endothelial cell contact areas,
whether in preexisting 'homing' vessels or in newly formed tumor vessels, suggests that connexin-43 can
serve as a potential marker of micrometastases and tumor vasculature and that it may play a role in the
early incorporation of endothelial cells into small tumors as seeds for vasculogenesis.
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Background
Intercellular communication via gap junctions between
neighboring cells contributes to the organization of cells
into functional tissues. Malignant tumors arising from
planar epithelial tissue lose the normal growth limit
caused by cell-cell contacts and form solid tumors in three
dimensions. This observation was the origin of the notion
that the loss of gap junctional intercellular communica-
tion (GJIC) plays an important role in tumorigenesis
[1,2]. Moreover, since invasive tumors are characterized
by cell detachment from the primary mass, a disruption of
intercellular junctions also became a de facto requirement
for metastasis [3,4].
A tumor cell undergoes a variety of stages in its life cycle:
its origin and growth in the primary site, cellular detach-
ment and intravasation, dissemination, settling in a new
site by endothelial attachment, and its growth as a meta-
static tumor including the development of its blood sup-
ply. While some of these stages, such as uncontrolled cell
division and cellular detachment, are associated with loss
of intercellular junctions, other stages, such as intravasa-
tion, endothelial attachment, and vascularization,
demand increased cell-cell contact. Therefore, it is clear
that a simplistic notion of the loss of cellular communica-
tion cannot fully describe the status of the cellular interac-
tion between tumor cells or between endothelial and
tumor cells during the whole metastatic process. An adhe-
sive interaction of tumor cells to endothelial cells during
'homing' is obvious. In addition, a role for connexins in
the facilitation of tumor growth, metastatic potential, and
tumor vascularization has been documented [5-12].
We have demonstrated that endothelial cells are incorpo-
rated early in breast cancer metastatic tumors in the lung
before the onset of hypoxia and they grow in mixed fash-
ion among the tumor cells, contributing to tumor vascu-
larization. These disparate cell types were shown to
establish functional GJIC both in vivo and in vitro. Since
the role of gap junctions in tumorigenesis and metastasis
has been controversial as outlined above, we addressed
the following questions in this work.
1. Does connexin-43 (Cx43) mediate GJIC between 4T1-
GFP cells and pulmonary microvascular endothelial cells
(PMVECs)?
2. Does Cx43 play a role in the attachment of breast cancer
cells to endothelial cells in the pulmonary circulation?
3. Is Cx43 upregulation associated with the sites of
micrometastatic foci and metastatic tumor vasculature?
To understand the role of Cx43 in the metastatic process,
we used cancer cell lines that overexpress wild-type Cx43,
express a dominant-negative mutant of Cx43, and a con-
trol mutant that does not affect endogenous Cx43 func-
tions. Using these Cx43 mutant cell lines, we show that in
a syngeneic mouse breast cancer experimental metastasis
model, Cx43 enhances breast cancer cell attachment to
the pulmonary endothelium. The results also indicate that
Cx43 can serve as a marker of micrometastases and tumor
vasculogenesis because of its significant upregulation in
areas of tumor cell-endothelial cell contact areas in vitro
and in vivo.
Methods
Cell culture and stable expression of Cx43 mutants
Pulmonary microvascular endothelial cells were obtained
from the Endothelial Cell Culture Core at the Center for
Lung Biology [13]. These cells are routinely obtained by
primary isolation from Sprague-Dawley rats and are used
within passage 12. These cells are maintained and propa-
gated in Dulbecco's Modified Eagle's Medium (DMEM)
with 10% fetal bovine serum.
The 4T1 cells (a mouse breast adenocarcinoma cell line)
were obtained from ATCC and were transfected with
enhanced green fluorescent protein (eGFP) vector (Clon-
tech, Mountain View, CA). Cells with stable GFP expres-
sion were separated by fluorescence activated cell sorting
and propagated and maintained in DMEM with 10% fetal
bovine serum. We have used the 4T1-GFP cells previously
in both experimental and spontaneous metastasis assays
[14-16]. Cells were grown in DMEM supplemented with
10% fetal bovine serum, 100 units/ml penicillin and 100
mg/ml streptomycin and were maintained at 37°C in a
moist environment of 95% air and 5% CO2 and sub-cul-
tured as required.
The Cx43 missense mutation G138R was made by site-
directed mutagenesis by changing the glycine to arginine
on position 138 in the amino acid sequence. The G138R
mutant expresses a mutant Cx43 that exhibits a domi-
nant-negative effect when expressed in cells with endog-
enous Cx43 [17]. This mutation is known to be present in
patients suffering from oculodentodigital dysplasia
[18,19]. The expressed Cx43-G138R protein translocates
to the membrane, and assembles as connexons, but does
not exhibit functional GJIC. Cells expressing the G138R
mutation exhibited a strong suppression of dye-transfer
even when they were co-expressed with wild-type Cx43
[17]. The G138R construct was ligated to a eukaryotic
expression vector containing the zeocin resistance gene
driven by the SV40 promoter. On the other hand, the
C61S mutant Cx43 protein lacks gap junction channel
forming abilities because of its cytoplasmic localization,
and apparently it does not interfere with functional gap
junction formation by endogenous normal Cx43 [20].
The Cx43 point mutation C61S was generated by site-BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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directed mutagenesis, replacing the cysteine residue in
position 61 with a serine residue. The C61S construct was
primarily used as a control. Both the C61S construct and
the cDNA for wild-type Cx43 (Cx43 overexpressors, or
Cx43OE) were ligated into the expression vector
pBEHpac18. 4T1-GFP tumor cells were also transfected
with the vector expressing two copies of wild-type Cx43
(Cx43OE) to enhance the formation of functional gap
junctions in tumor cells (positive control).
Plasmid DNA was extracted from filter paper spots into
500 μl of Tris-EDTA buffer (10 mM Tris-Cl, pH 7.5 and 1
mM EDTA), electroporated into competent bacteria, and
allowed to grow overnight with the appropriate antibiotic
for selection. The plasmid DNA was isolated using Mini-
prep (Qiagen) and samples were run on a gel to confirm
the size of the plasmid. In addition, samples of the plas-
mid DNA were sent to the GeneLab at Louisiana State
University (Baton Rouge, LA) for amplification and
sequencing. The presence of each mutation was con-
firmed by comparison with wild type using BLAST soft-
ware.
4T1-GFP cells were grown to 75–95% confluency in 60
mm culture dishes and transfected at 37°C in Opti-MEM
medium (Invitrogen, Carlsbad, CA) containing 75 μl of
Lipofectamine 2000 and 30 μg of plasmid DNA. After 24
hours, the DNA/Lipofectamine suspension was removed
and replaced with culture medium containing the appro-
priate antibiotics. Cells were selected with 2 μg/ml puro-
mycin (InvivoGen, San Diego, CA) for the C61S and
Cx43OE constructs or with 500 μg/ml of zeocin (Invitro-
gen) for the G138R construct. The selection process con-
tinued for 2 weeks on the puromycin resistance constructs
and for 4 weeks on the zeocin resistant construct. Cells
were maintained afterwards in normal medium contain-
ing the appropriate amounts of antibiotics.
Evaluation of gap junctions by dye-transfer assays in vitro 
and in situ
The presence of functional gap junctions was evaluated
using a fluorescent dye-transfer assay. Sub-confluent
monolayers of PMVECs in glass-bottomed 35 mm dishes
were used. Endothelial cells were washed with Kreb's
Ringer bicarbonate solution (KRB), with 5% clinical grade
dextran and 10 mM glucose at pH 7.4, and incubated with
5 μM Calcein Orange Red AM (gap junction-permeable
fluorescent dye, molecular weight 790 Da) in KRB for 30
minutes. The acetoxymethyl ester (AM) group of the dye
is hydrolyzed by esterases in a viable cell, rendering the
dye polarized and trapped within the cell, but allowing its
transfer to adjacent cells via functional gap junctions.
After dye loading, the endothelial cells were washed five
times to remove the free dye from the medium. Experi-
ments were performed in KRB in the absence of serum.
Then 4T1-GFP cells (transferred-dye acceptors) were
placed on the labeled endothelial cells (dye donors) at a
ratio of 1:500 (acceptor:donor). After incubating for up to
3 hours at 37°C, the cells were washed and visualized
using a Nikon TE2000 epifluorescence microscope. For in
situ dye-transfer studies, 5 μM Cell Tracker Orange was
used to label pulmonary endothelial cells in situ and then
Calcein Green AM labeled 4T1 cancer cells (without GFP)
were administered in the perfusate of mouse lungs and
dye transfer to endothelial cells in situ was evaluated by
confocal microscopy (BioRad Radiance 2000, Hercules,
CA). All fluorescent probes were obtained from Invitrogen
Molecular Probes (Eugene, OR).
Immunocytofluorescence for Cx43
Following stable transfection with wild-type or mutant
DNA constructs, cells were grown on glass-bottomed 35
mm dishes and were fixed in ice-cold 70% methanol and
20% acetone solution for 10 minutes at 4°C, then rinsed
with phosphate buffered saline (PBS) and prepared for
immunolabeling. Non-specific antigen sites were blocked
with 2% bovine serum albumin (BSA) in PBS, immunola-
beled with the Cx43 primary antibody, washed with PBS
and labeled with a fluorescent secondary antibody. Cells
were then washed in PBS, air-dried, and cover-slipped
with a drop of the mounting medium Gold Antifade Rea-
gent containing 4',6-diamidino-2-phenylindole (DAPI)
for nuclear staining (Invitrogen, Carlsbad, CA).
Western blot analysis and densitometry
Lysates of 4T1-GFP cells collected from stable colonies
after transfection with 30 μg of wild-type or mutant cDNA
encoding C61S or G138R were subjected to Western blot-
ting. Blots were immunolabeled for Cx43 using a mouse
anti-Cx43 monoclonal antibody (catalog #13-8300,
Zymed, San Francisco, CA). Unsaturated blots were
scanned and densitometry was performed using Quantity
One software (BioRad, Hercules, CA).
Immunohistochemistry/immunohistofluorescence
Immunohistochemistry was carried out on paraffin-
embedded mouse lung tissue sections containing tumor
segments. Sections were deparaffinized in two changes of
xylene then hydrated in sequential changes of decreasing
concentrations of ethanol (100%, 90%, 70%, 50%, 30%)
followed by a rinse in distilled water. Antigen retrieval was
performed by immersing the slides in sodium citrate
buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0)
at boiling temperature. Slides were then cooled at room
temperature for 20 minutes and rinsed in PBS buffer con-
taining 0.1% Triton X-100. Nonspecific binding was
blocked using 5% goat serum and 5% BSA and 0.3% Tri-
ton X-100 for 30 minutes. Slides were incubated with
mouse anti-Cx43 monoclonal antibody (#35-5000,
Zymed, San Francisco, CA) for 2 hours at room tempera-BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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ture. Slides were rinsed again and incubated for 1 hour
with a secondary antibody conjugated to a fluorescent
probe (Alexa Fluor 647) or horseradish peroxidase (HRP).
Slides were then washed in PBS, air-dried, and cover-
slipped with a drop of the mounting medium Gold Anti-
fade Reagent containing DAPI for nuclear staining (Invit-
rogen, Carlsbad, CA).
Quantification of tumor cells adhering to the lung 
vasculature
Immunohistofluorescence and immunohistochemistry
slides were imaged using the Nikon TE2000 epifluores-
cence microscope with a ×60 objective. Three lungs from
animals containing tumors derived from each cell line
were used. Four slides from each lung were used for imag-
ing. Twenty contiguous picture frames per slide were
acquired. Cells were counted in each stitched meta-pic-
ture.
Fluorescence microscopy
A high-resolution digital fluorescence video imaging sys-
tem based on a Nikon TE-2000 inverted microscope was
used. The imaging system is fitted with two automated 10-
position filter wheels for both excitation and emission
(Sutter Instruments, model Lambda 10-2), an automated
dichroic filter cube changer (Nikon), XYZ axis mecha-
nized stage (Prior Scientific, Inc.), a high-resolution 12-bit
Orca-100 ER IEEE1394 digital camera (Hamamatsu Inc.),
MetaMorph 7.5 image acquisition, processing, and analy-
sis software with three-dimensional reconstruction and
point-spread function-based deconvolution capabilities
(Universal Imaging/Molecular Devices). Separately
addressable excitation, dichroic, and emission filters
allow the maximum flexibility for multiple wavelength
and ratio imaging in this system.
For imaging metastatic tumors of GFP-expressing 4T1
cells in situ in the intact mouse lung, an established iso-
lated lung microscopy method was utilized [15,21]. Some
isolated lungs taken from animals with experimental
metastases were perfused with Griffonia simplicifolia lec-
tin conjugated with TRITC (Molecular Probes, Eugene,
OR) via the pulmonary artery for 30 minutes to label the
pulmonary and the tumor microvasculature. The lungs
were placed in a specially designed Plexiglas chamber over
a coverslip-window at the bottom with the posterior sur-
face of the lung gently touching the coverslip. Subpleural
tumors were directly visualized at high magnification
(×600) by epifluorescence microscopy using appropriate
filters and illumination. Image processing and analysis
were performed with MetaMorph software (Molecular
Devices, Sunnyvale, CA).
Experimental metastasis model
A syngeneic breast cancer experimental metastasis model
was used in the study as described previously [22]. The
4T1-GFP cell line was derived from the 4T1 mouse mam-
mary adenocarcinoma cell line (# CRL-2539, ATCC, Man-
assas, VA) by stable transfection with eGFP (Clontech,
Mountain View, CA). We injected young nu/nu mice
(Charles River) into the tail-vein with single-cell suspen-
sions of 4T1-GFP cells at 30 × 103 cells per gram body
weight followed by lung isolation, perfusion, and intact
organ epifluorescence microscopy up to 21 days after
injection. The volume of injected medium with cells was
100 μl. Animals were monitored on a daily basis for signs
of respiratory distress. The research was conducted under
a protocol reviewed and approved by the University of
South Alabama Institutional Animal Care and Use Com-
mittee.
Statistical analysis
Data analysis was performed using SigmaStat (Systat Soft-
ware Inc., San Jose, CA) using one-way analysis of vari-
ance and Bonferroni's test. Data are expressed graphically
as means ± standard error of the mean (SEM) using Sig-
maPlot (Systat Software Inc., San Jose, CA). Differences
were considered significant with P < 0.05.
Results
Cx43 expression in tumor cell-endothelial cell co-culture 
in vitro and in pulmonary metastasis in vivo
Cx43 is upregulated in tumor cell-endothelial cell contact areas
Co-culture of 4T1-GFP cells (green cytoplasmic staining
with blue nuclei) and PMVECs (blue nuclei without cyto-
plasmic staining) lead to upregulation of Cx43 expression
(red) at the contact areas between the tumor cells and
endothelial cells (Figure 1a, b, c, white arrows). Cells not
in a heterologous contact demonstrate baseline expres-
sion of Cx43 (Figure 1a and 1b, yellow arrows). An over-
lay of the differential interference contrast (DIC) image
demonstrates the intense expression of Cx43 in the con-
tact areas (white arrow) between an endothelial cell on
the left and a 4T1-GFP cell on the right (Figure 1d). Immu-
nohistofluorescence of a lung metastatic tumor section
stained for both Cx43 (red) and for CD31 (green) with
nuclear DAPI staining in blue demonstrates that more
than 95% of endothelial cells within the tumor mass
(green) have an increase in Cx43 staining (Figure 1e,
arrows). Immunofluorescence of a fixed mouse lung sec-
tion after 12 hours of tail vein injection of tumor cells
depicts tumor cells lodged inside pulmonary microvascu-
lature with concomitant upregulation of Cx43 in both the
endothelial cells (Figure 1f, white arrow) and the tumor
cells (Figure 1f, yellow arrow).BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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Upregulation of connexin-43 in tumor cell-endothelial cell contact areas in vitro and in vivo Figure 1
Upregulation of connexin-43 in tumor cell-endothelial cell contact areas in vitro and in vivo. (a)-(d) Immuno-
cytofluorescence detecting connexin-43 (Cx43; red) in co-culture of 4T1-GFP cells (green cytoplasmic staining with blue 
nuclei) and pulmonary microvascular endothelial cells (PMVECs; blue nuclei without cytoplasmic staining). 4T1-GFP and 
PMVECs were plated together in co-culture and examined under the green fluorescent protein (GFP) channel (4T1 cells), UV-
channel (nuclei), and Cy5-channels (Cx43), and shown as an overlay of all channels indicating the location of 4T1-GFP cells 
(green), nuclei of both cell types (blue), and Cx43 (red). In (a), (b), and (c), upregulation of Cx43 expression (red) is seen at the 
contact areas between the tumor cells and PMVECs (white arrows). Cells not in a heterologous contact show little expression 
of Cx43 (yellow arrows). Panel (d) shows an additional overlay of the DIC image to further emphasize the Cx43 intense 
expression at the areas of contacts (white arrow) between an endothelial cell on the left and a 4T1-GFP cell on the right. (e) 
Immunohistofluorescence of a lung metastatic tumor section stained for both Cx43 (red) and CD31 (green) with nuclear DAPI 
staining in blue. Most endothelial cells within the tumor mass (green) showed an increase in Cx43 staining (arrows). (f) Immu-
nohistofluorescence of a fixed mouse lung section after 12 hours of tail vein injection of tumor cells. Autofluorescence of lung 
tissue in the GFP-channel and the GFP fluorescence of 4T1-GFP cells were assigned the blue pseudocolor for better contrast 
with the Cy5-channel Cx43 signal (red). Tumor cells can be seen lodged inside pulmonary microvessels. The image clearly indi-
cates the upregulation of Cx43 in both the endothelial cells (white arrow) and the tumor cells within the vessels adhering to 
the vessel walls (yellow arrow). The scale bar in (a)-(d) is 10 μm and (e), (f) is 25 μm.BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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Upregulation of Cx43 marks the sites of micrometastatic foci and 
metastatic tumor vasculogenesis
Figure 2 demonstrates that Cx43 expression marks the
sites of micrometastases in sections from lungs after tail
vein injection of tumor cells. Cx43 (red) was upregulated
in vessels containing control 4T1 tumor cells (Figure 2a,
yellow arrow), while vessels not containing tumor cells in
the same section had barely detectable Cx43 signals (Fig-
ure 2a, white arrows). Lung sections with C61S expressing
tumor cells exhibited similar pattern of Cx43 expression
(Figure 2b), whereas those with the dominant-negative
G138R expressing cells exhibited decreased staining for
Cx43 (Figure 2c). In contrast, in lung sections with Cx43
overexpressing tumor cells, a significant increase in the
number of intravascular tumor cells, an increase in the
number of vessels containing adherent tumor cells, and
induction of Cx43 were seen (Figure 2d). Ninety five per-
cent of the vessels with Cx43 staining appeared to contain
tumor cells (Figure 2d, yellow arrows). Upregulation of
Cx43 in tumor cell-endothelial cell contact areas in one of
the larger vessels is shown using DIC (Figure 2e), Cx43
signal (white, Figure 2f), overlay of DIC and Cx43 signal
(Figure 2g) and overlay of GFP (tumor cells, green), DAPI
(nuclei, blue), and Cx43 (red, yellow arrows) signals (Fig-
ure 2h).
Intratumor vessels and metastatic foci demonstrate
increased Cx43, making Cx43 a potential marker for not
only micrometastases, but also for tumor vasculature (Fig-
ure 3). Figures 3a and 3b depict lower-magnification
images of lung sections containing control 4T1-GFP
tumor cells. Cx43 (red) was upregulated in the vessels that
contained tumor cells (yellow arrow) while vessels with-
out tumor cells in them had minimal Cx43 signals (white
arrows). A metastatic tumor in the lung with a high level
of Cx43 expression in the tumor vasculature is visible in
Figure 3c (arrow). Figure 3d shows a higher-magnification
image of the same tumor highlighting the region with the
high Cx43 signal. Another metastatic tumor at low magni-
fication (Figure 3e) demonstrates Cx43 upregulation
within tumor vessels at higher magnification (Figure 3f).
Figure 3g shows a vessel containing tumor cells and exhib-
iting strong Cx43 signal (yellow arrow), while a neighbor-
ing vessel with a stack of red blood cells (white arrow) but
no tumor cells shows no Cx43 reactivity. A vessel from a
control lung treated with non-immune mouse IgG instead
of the primary antibody for Cx43 showed no staining of a
vessel (arrow) in which red blood cells can be seen due to
their autofluorescence in the GFP channel (Figure 3h).
Role of Cx43 in tumor cell-endothelial cell interaction in 
vitro
Cx43 mediates border-sharing and co-growth of 4T1-GFP cells and 
PMVECs
In co-culture, 4T1-GFP and PMVECs form a monolayer
where the cancer cells and endothelial cells could not be
identified in DIC pictures (Figure 4A-a,b), but their mixed
growth can be ascertained by overlaying the cancer cell
pictures in the GFP channel (Figure 4A-c,d) with the DIC
pictures (overlays shown in Figure 4A-e,f). Co-culture of
wild-type 4T1-GFP, C61S, or Cx43OE and PMVECs exhib-
ited the mosaic growth pattern and the presence of shared
borders (Figure 5). In contrast, 4T1-GFP cells harboring
the mutant G138R grew on top of endothelial cells with-
out integration into the endothelial monolayer (Figure 5),
indicating a possible lack of intercellular communication
between the two cell types. This suggests that defective gap
junctional communication results in inhibition of coordi-
nation required for border-sharing and co-growth.
Cx43 mediates establishment of functional GJIC between 4T1-GFP 
cells and PMVECs
The presence of endogenous Cx43 was demonstrated in
wild-type 4T1 cells where Cx43 is localized mostly at the
plasma membrane between the cells (Figure 6A, 4T1,
white arrows). The G138R dominant-negative mutant as
well as the Cx43 wild-type Cx43OE cell line expressed
Cx43 both at the plasma membrane (white arrows) and in
the cytoplasm (yellow arrows). The mutant C61S
expressed a non-targetable form of Cx43 mostly in the
cytoplasm (Figure 6A, yellow arrows). Quantification of
the immunocytofluorescence signal of Cx43 in 4T1-GFP
cells expressing mutant and wild-type Cx43 demonstrated
an at least two-fold increase in Cx43 expression compared
with endogenous expression (control) or with mock
transfection (Figure 6B). Western blot analysis indicated
increased expression of Cx43 forms in transfected cells
compared with non-transfected 4T1-GFP cells (Figure
6C). The quantification of bands from three blots illus-
trates that the transfected cells show an at least a two-fold
increase in Cx43 expression (P < 0.05) compared with
wild-type 4T1-GFP cells (Figure 6C, bar graph).
When 4T1-GFP cells were placed on top of Calcein Red
Orange labeled subconfluent monolayer of endothelial
cells, the 4T1-GFP cells established functional gap junc-
tions with the endothelial cells. In tumor cells (green of
GFP) that were in close contact with endothelial cells,
transfer of Calcein Orange Red from endothelial cells can
be observed (red color inside green cells; Figure 7A, 4T1,
and Figure 4B, black bar). Dye transfer was significantly
reduced in tumor cells expressing the G138R mutant (Fig-
ure 7A, G138R, and Figure 7B, red bar) and in the pres-
ence of gap junctional inhibitor 18β-glycyrrhetinic acid
(30 μM; Figure 7B, blue bar). On the other hand, overex-BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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Connexin-43 expression marks the sites of micrometastases Figure 2
Connexin-43 expression marks the sites of micrometastases. (a)-(d), (h) Immunohistofluorescence fixed sections of 
mouse lung after 12 hours of tail vein injection of 4T1-GFP cells or connexin-43 (Cx43) mutant variants C61S, G138R, or 
Cx43OE. Autofluorescence of lung tissue and 4T1-GFP fluorescence (green fluorescent protein (GFP) channel green color) 
and Cx43 signal (Cy5-channel red color), and nuclear staining (DAPI channel blue color) were overlaid. Panels (a)-(d) show 
images of lung sections taken at low magnification. Panel (a) shows the sections from a lung after tail vein injection of control 
4T1-GFP tumor cells. Cx43 (red) was upregulated in vessels containing tumor cells (yellow arrow), while vessels not containing 
tumor cells from the same lung had barely detectable Cx43 signal (white arrows). Lung sections with C61S expressing tumor 
cells exhibited similar pattern of Cx43 expression (b), whereas those with the dominant-negative G138R expressing cells 
exhibited decreased staining of Cx43 (c). In contrast, in lung sections with Cx43 overexpressing tumor cells, a significant 
increase in the number of intravascular tumor cells, an increase in the number of vessels containing adherent tumor cells, and 
induction of Cx43 was seen (d). Most of the vessels with Cx43 staining appeared to contain tumor cells (yellow arrows). Panels 
(e)-(h) show higher-magnification images of lung sections containing tumor cells overexpressing Cx43. Panel (e) shows a DIC 
image of a vessel within the lung containing tumor cells; (f) shows the Cx43 signal in the same vessel; and (g) is an overlay 
showing the induction of Cx43 in both endothelium and tumor cells in red color. Panel (h) shows another overlay of the same 
image of the green (tumor cells, autofluoresence of lung tissue and red blood cells), blue (nuclei), and red (Cy5 for Cx43) chan-
nels. Scale bars in (c), (d) are 100 μm (the same scale is used in (a) and (b)) and the scale bar in (h) is 25 μm (the same scale is 
used in (e), (f), and (g)).BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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Intratumor vessels and metastatic foci demonstrate increased connexin-43 Figure 3
Intratumor vessels and metastatic foci demonstrate increased connexin-43. Immunohistofluorescence for con-
nexin-43 (Cx43) of mouse lung sections 12 days after tail vein injection of 4T1-GFP control cells or of cells expressing Cx43 
variants C61S, G138R, or Cx43OE. Lung tissue autofluorescence and tumor cell green fluorescent protein (GFP) fluorescence 
is pseudocolored green color and the Cx43 signal (Cy5-channel) is shown in red. Nuclear staining with DAPI is shown in blue. 
Each picture is an overlay of these three channels. (a), (b) Lower-magnification images of lung sections containing control 4T1-
GFP tumor cells. Cx43 (red) was upregulated in the vessels that contained tumor cells (yellow arrow) while vessels without 
tumor cells in them had minimal Cx43 signal (white arrows). (c) A metastatic tumor in the lung with enriched Cx43 signal asso-
ciated with the tumor vasculature. (d) A higher-magnification image of the same tumor highlighting the region with the high 
Cx43 signal. (e) Another metastatic tumor with (with a higher-magnification image in (f)) demonstrating the Cx43 upregulation 
within tumor vessels. (g) One vessel containing tumor cells and exhibiting high Cx43 signal (yellow arrow), while a neighboring 
vessel with a stack of red blood cells (white arrow) but no tumor cells shows no Cx43 reactivity. (h) A vessel from a control 
lung with non-immune mouse IgG used in place of the primary antibody showing no staining of a vessel (arrow) in which red 
blood cells can be seen due to their autofluorescence in the GFP channel. The scale bar in (a), (b), (c), and (e) is 100 μm and 
the scale bar in (d) and (f) (which are to the same scale as (g) and (h)) is 25 μm.BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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pressing wild-type Cx43 enhanced dye transfer (Figure 7A,
Cx43OE, and Figure 7B, green bar). The expression of
C61S mutant did not affect dye transfer via endogenous
Cx43 (Figure 7A, C61S, and Figure 7B, yellow bar).
Immunostaining revealed the presence of Cx43 at the con-
tact area of some tumor cells that were attached to the api-
cal surface of underlying endothelial cells (Figure 10A).
Role of Cx43 in the metastatic efficiency
Cx43 facilitates tumor cell adhesion to lung endothelium
A role for Cx43 in tumor cell attachment to the pulmo-
nary endothelium in vivo is demonstrated by the follow-
ing observations. Cx43 expression, detected by
immunofluorescence (red pseudocolor), was upregulated
in the tumor cells and in the endothelium of the vessels
with control tumor cells (Figure 8, 4T1). Tumor cells with
C61S mutation showed similar levels of Cx43 expression
in the endothelium as for control cells (Figure 8). In both
cases, the number of arrested cells within the vasculature
was similar. Fewer cells with the G138R mutation were
found arrested (Cx43 signal in red; Figure 8). In contrast,
lung vasculature containing 4T1-Cx43OE tumor cells
showed intense Cx43 staining of the endothelium and the
tumor cells (Figure 8). There were also significantly more
tumor cells in the blood vessels of these lungs. These data
indicate a cell adhesion role for functional Cx43 in breast
cancer metastasis to the lung in this syngeneic model.
Similar results were obtained with immunohistochemical
analysis of lung tissue sections containing metastatic
tumors of the variant Cx43 4T1-GFP cell lines. Figure 9A,
4T1, depicts a vessel containing red blood cells and dark
nuclei of adherent control 4T1-GFP cells within it. The
number of vessel-adherent tumor cells expressing the
C61S mutation was comparable to that for control cells
(Figure 9A). On the other hand, the number of adherent
tumor cells with the G138R mutated Cx43 was signifi-
cantly lower (Figure 9A, G138R). Tumor cells overexpress-
ing Cx43 appear to populate the vessels in much greater
numbers (Figure 9A, Cx43OE). Quantification of the
tumor cell numbers adhering to the lung endothelium
shows that dominant negative G138R expression reduced
the number of arrested tumor cells (Figure 9B, red bar),
while overexpressing wild-type Cx43 increased the
Tumor cells and endothelial cells share common borders in  vitro Figure 4
Tumor cells and endothelial cells share common bor-
ders in vitro. (a), (b) 4T1-GFP and pulmonary microvascular 
endothelial cells were plated together in co-culture and 
examined by DIC imaging. (c), (d) The same fields were 
imaged in the green fluorescent protein (GFP) channel to 
reveal the presence of the 4T1-GFP cells. (e), (f) The images 
were overlaid to show the location and shared borders 
between the tumor cells and the endothelial cells.
Patterns of co-growth of 4T1-GFP breast cancer cells (in  green) and pulmonary microvascular endothelial cells (DIC  channel, gray) in vitro Figure 5
Patterns of co-growth of 4T1-GFP breast cancer cells 
(in green) and pulmonary microvascular endothelial 
cells (DIC channel, gray) in vitro. Co-culture of wild-type 
4T1-GFP cells (4T1), Cx43-C61S mutation expressing 4T1-
GFP cells (C61S), and connexin-43 overexpressing cells 
(Cx43OE), and pulmonary microvascular endothelial cells 
exhibited side-by-side growth and shared borders. In con-
trast, 4T1-GFP cells expressing the mutant Cx43-G138R 
(G138R) grew on top of endothelial cells without integration 
into the monolayer.BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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Expression of connexin-43 by the mutant variants Figure 6
Expression of connexin-43 by the mutant variants. (A) Immunocytofluorescence analysis of connexin-43 (Cx43) expres-
sion in wild-type 4T1-GFP tumor cells and in 4T1-GFP cells transfected with expression vectors of the mutant G138R and 
C61S in addition to a vector expressing two copies of wild-type Cx43 (Cx43OE). Endogenous Cx43 in wild-type 4T1-GFP cells 
is present mostly at the plasma membrane between the cells (3A, 4T1, white arrows). The G138R dominant-negative mutant 
was expressed both at the plasma membrane (white arrows) and in the cytoplasm (yellow arrow). Wild-type overexpression 
led to upregulation of Cx43 in both the plasma membrane (white arrows) and in the cytoplasm (yellow arrows, 3A, Cx43OE). 
Cx43 with the C61S mutation was mostly in the cytoplasm (yellow arrows, 3A, C61S). (B) Quantification of the immuno-
cytofluorescence signal of Cx43 in 4T1-GFP cells expressing mutant and wild-type Cx43. All of the transfectants showed at 
least a factor or two more Cx43 expression compared with endogenous expression (control) or with mock transfection. (C) 
Western blot analysis showing increased expression of Cx43 forms in transfected cells when compared with non-transfected 
4T1-GFP cells. The quantification of bands from three blots illustrates that the transfected cells show an at least two-fold 
increase in Cx43 expression compared with wild-type 4T1-GFP cells. *P < 0.05.BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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Dye transfer between 4T1-GFP and pulmonary microvascular endothelial cells Figure 7
Dye transfer between 4T1-GFP and pulmonary microvascular endothelial cells. (A) Subconfluent monolayers of 
pulmonary microvascular endothelial cells in coverglass-bottomed dishes was labeled with 5 μM Calcein Red AM and then 
thoroughly washed for removal of extracellular dye. 4T1-GFP cells with or without connexin-43 (Cx43) mutation variants 
were deposited into the dish and placed in a cell culture incubator. After 1 hour, the cells were imaged in the red (for Calcein 
Red) and green fluorescent protein (GFP) channels and the pictures were overlaid. In tumor cells (green) that were in close 
contact with endothelial cells, transfer of Calcein Red can be observed (red color inside green cells). (B) Quantification of 4T1-
GFP cells exhibiting dye transfer from endothelial cells. Dye transfer was significantly reduced in 4T1-GFP tumor cells express-
ing the G138R Cx43 mutant (red bar) and in the presence of gap junctional inhibitor 18β-glycyrrhetinic acid (30 μM) (blue bar). 
On the other hand overexpressing wild-type Cx43 enhanced dye transfer (green bar). The expression of C61S mutant did not 
seem to affect dye transfer (yellow bar).BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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number of arrested tumor cells within the lung vascula-
ture (Figure 9B, green bar).
Discussion
Although a variety of connexins are involved in GJIC in
different cell types, the expression of Cx43 in vascular
endothelial cells and in many tumor cell lines indicates a
primary role for this protein in the heterologous gap junc-
tional communication during tumor cell-endothelial cell
interaction [23-28]. Functional GJIC between tumor cells
and vascular endothelial cells mediated via Cx43 has been
demonstrated [9,23,25]. Consequently, it was also shown
that quantitative and qualitative changes in connexin
expression are associated with tumor progression, prolif-
eration, invasion, and metastasis [9,25,29]. Cx43
enhanced the adhesiveness and mediated the invasion in
malignant gliomas [20]. In addition, the increased expres-
sion of specific connexins correlated with increased inva-
siveness of lung squamous cell carcinoma or NIH3T3-Ras
cells [29,30] and Cx43 expression was upregulated in ure-
thane-induced mouse lung adenomas [31]. Increased lev-
els of Cx43 mRNA was found in hepatocellular carcinoma
tissues [32] and in the stroma of multiple intestinal neo-
plasia-mice adenomas [23]. Expression of Cx43 in mam-
mary carcinoma cell lines lacking endogenous Cx43
enabled the formation of heterocellular GJIC with micro-
vascular endothelial cells and increased their diapedesis
[12]. Increased cytosolic and plasma membrane expres-
sion of Cx43 in lymph node metastases of breast cancer
was demonstrated [11]. Cx43 was detectable in normal
lung, smaller size tumor, and larger size mouse lung
tumors [24]. Our study shows a role for Cx43 in breast
cancer metastasis to the lung in a syngeneic, murine exper-
imental metastasis model.
Although connexins are classically considered as gap-
junctional proteins, non-junctional roles for connexins in
hemichannels with ion-channel-like functions or possess-
ing channel-independent, signaling-type functions have
received considerable attention recently [33,34]. Adhe-
sion-mediated establishment of functional GJIC between
lung-metastatic B16F10 melanoma cells and endothelium
has been shown to be dependent on the expression of
Cx43 in both cell partners [35].
The major conclusion of this study is that gap junctional
communication via Cx43 facilitates metastatic homing by
increasing the arrest of cancer cells in the lung vasculature.
The reduced attachment of cancer cells with the domi-
nant-negative G138R that allows formation of gap-junc-
tion plaques but not of functional junctions suggests a
positive correlation between the loss of intercellular com-
munication and the number of adherent tumor cells in
the lungs. The idea that the formation of functional gap
junctions between a cancer cell and the endothelial cell is
critical for tumor cell adhesion to the pulmonary
endothelium is novel. Normal gap junction plaques are
found in the lateral membranes of cells, below the level of
the tight junction belt. In the case of heterologous gap
junction formation with adherent cells, the apical surface
of the endothelial cells comes into contact with the sur-
face of cancer cells (Figure 10). Therefore, a role for con-
nexins in heterologous adhesion or in establishment of
functional GJIC would require the presence of connexins
at the apical surface of endothelial cells, as demonstrated
for Cx43 in Figure 10A. Very high concentration of Cx43
has been demonstrated at the apical surface of epithelial
cells [36]. The residual coupling between Cx43G138R
expressing tumor cells and endothelial cells expressing
wild-type Cx43 in comparison to 18β-glycyrrhretinic acid
treated cells (Fig 7B red and blue bars) is mediated
through heterotypic Cx43G138R-Cx43WT channels.
These channels were recently described as strongly inhib-
Role of connexin-43 in tumor cell attachment to lung  endothelium Figure 8
Role of connexin-43 in tumor cell attachment to lung 
endothelium. Immunofluorescence for connexin-43 (Cx43) 
of mouse lung sections 12 hours after tail vein injection with 
4T1-GFP control cells or cells expressing Cx43 variants 
C61S, G138R, or Cx43OE. Autofluorescence of lung tissue 
and red blood cells in the green fluorescent protein (GFP) 
channel (green), Cx43 signal in the Cy5 channel (red), and 
the nuclear DAPI signal (blue) were overlaid. Panel '4T1' 
(control 4T1-GFP): Cx43 (red) was upregulated in the tumor 
cells and in the endothelium of the vessels with tumor cells. 
Panel 'C61S': tumor cells with C61S mutation, showing simi-
lar level of Cx43 expression as for control cells. Panel 
'G138R': cells with dominant negative G138R mutation, 
showing Cx43 (red) around a few tumor cells within the ves-
sels with a limited number of tumor cells in the vessels. In 
contrast lung segments containing 4T1 tumor cells overex-
pressing Cx43 show intense Cx43 staining and the vessels 
contained large number of tumor cells (see panel 'Cx43OE'). 
The scale bar is 25 μm for all panels.BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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Connexin 43 facilitates tumor cell attachment to lung endothelium Figure 9
Connexin 43 facilitates tumor cell attachment to lung endothelium. (A) Hematoxylin-eosin staining of mouse lung 
sections 12 hours after tail vein injection with 4T1-GFP control cells or cells expressing connexin-43 (Cx43) variants C61S, 
G138R, or Cx43OE. Panel '4T1': a vessel containing red blood cells and dark nuclei of adherent 4T1-GFP control cells within it. 
Panel 'C61S': C61S expressing tumor cells show a comparable density of tumor cell nuclei in blood vessels. Panel 'G138R': 
dominant-negative G138R expressing tumor cells show a decreased number of tumor cells inside vessels. In contrast, tumor 
cells overexpressing Cx43 appear to populate the vessels in much larger number (see panel 'Cx43OE'). (B) Quantification of 
the tumor cell numbers adhering to the lung endothelium showing that dominant-negative expression Cx43 reduced the 
number of the tumor cells within the vessels in the lung (red bar), while overexpressing wild-type Cx43 resulted in more 
tumor cells within the lung vasculature (black bar). *P < 0.05 versus 4T1. The results represent three lungs for each condition, 
four slides per lung, and 20 contiguous picture frames per slide.BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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ited but not completely abolished in their function [37].
The decreased attachment efficiency with the G138R
mutation might also be the result of alteration in confor-
mation of the Cx43 protein. The C61S mutant does not
express the mutated Cx43 in the membrane; therefore, it
did not alter the cell adhesion mediated by endogenous
Cx43. The increased adhesion of cancer cells with overex-
pression of wild-type Cx43 further confirms the role for
Cx43 in tumor cell attachment efficiency as a result of
enhanced GJIC.
The marked upregulation of Cx43 in tumor cell-endothe-
lial cell contact areas, whether in preexisting 'homing' ves-
sels or in newly formed tumor vessels, indicates that Cx43
can serve as a marker of micrometastases and tumor vas-
culogenesis. This raises the possibility of a role for Cx43 in
the early incorporation of endothelial cells into pre-
hypoxia size tumors as seeds for vasculogenesis.
Cx43 has been shown to enhance angiogenesis in vitro
[38]. Tube formation by human umbilical vein endothe-
lial cells cocultured with Cx43-transfected malignant gli-
oma cells or with naturally Cx43-expressing malignant
glioma cells was significantly increased compared with
tube formation by endothelial cells alone [5]. In addition,
upregulation of Cx43 in the hypertrophic myocardium in
mice suggested its role in cardiac angiogenesis [38]. These
reports are consistent with our finding of upregulation of
Cx43 in cancer cell-endothelial cell contact areas. This
selective upregulation of Cx43 can be exploited as a
marker for sites of intravascular metastases as well as for
vasculogenic loci within metastatic tumors. Previously, it
had been shown that Cx43 mRNA in normal tissue sur-
rounding lung tumor may act as a molecular marker of
nodal micrometastasis in non-small cell lung cancer [39].
The association between cancer and the lack of communi-
cation between cancer cells set the stage for a role of dys-
functional gap junctions in carcinogenesis nearly 40 years
ago [40]. Since then, both increased and decreased levels
of various connexins shown in different models of pri-
mary and metastatic tumors had generated multiple inter-
pretations [41]. The difficulty in developing a unified
hypothesis regarding the role of connexins in primary and
secondary carcinogenesis may be associated with a multi-
plicity of contradictory functions that the metastatic cell
has to perform during intravasation and distant localiza-
tion. A recent review predicted that "a gain of function (of
gap junctions) may characterize the metastatic stage" [41].
Our results confirm this prediction and we hope that they
will set the stage for a renewed assessment of the role of
connexins in metastatic tumorigenesis and tumor vascu-
logenesis.
Conclusion
Cx43 facilitates metastatic 'homing' by increasing adhe-
sion of cancer cells to the lung endothelial cells. The
marked upregulation of Cx43 in tumor cell-endothelial
cell contact areas, whether in preexisting 'homing' vessels
Apical endothelial cell connexin 43 forms heterologous gap  junctions Figure 10
Apical endothelial cell connexin 43 forms heterolo-
gous gap junctions. (A) Connexin-43 (Cx43) localization at 
the interface between the endothelial apical surface and the 
4T1-GFP cell coupling surface. The picture shows a side view 
of a 4T1-GFP cell sitting on top of an endothelial cell in cul-
ture. The side view was generated from a three-dimensional 
reconstructed image from a stack of 20 z-axis optical sec-
tions of the cells. (B) Model of cancer cell attachment to 
endothelial cells. The gap junctional coupling mediated via 
Cx43 would require its localization on the surfaces in con-
tact: the apical surface of the endothelial cells and the cou-
pling surface of the cancer cell. Our results suggest that the 
initial attachment mediated via the classical cell adhesion 
molecules (such as α3β1 integrin and vascular laminin-5 [42]) 
may not be sufficient for retention of the cells and the crea-
tion of metastatic foci. This requires establishment of func-
tional gap junctions between the apposing surfaces brought 
together by cell adhesion molecules. In our model, the 
required molecule playing an important role in the adhesion 
efficiency is Cx43, as demonstrated by the loss of adhesion 
with gap junctional intercellular communication incompetent 
G138R mutant variant in the cancer cell alone. How the 
communication helps the establishment of the metastatic foci 
is unknown at present, but we speculate that the coordina-
tion between the disparate cell types helps them to recog-
nize each other as partners and makes them grow together 
to become a tumor mass with blood supply.BMC Medicine 2008, 6:20 http://www.biomedcentral.com/1741-7015/6/20
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or in newly formed tumor vessels, suggest that Cx43 can
serve as a potential marker of micrometastases and tumor
vasculature and that it may play a role in the early incor-
poration of endothelial cells into small tumors as seeds
for vasculogenesis.
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